aluates Reports

$ 0.0

Automative

Global Oligonucleotides Market Research Report 2026

Published Date: 2026-03-05

Report Code: QYRE-Auto-32Y361

Global Oligonucleotides Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Oligonucleotides Market Research Report 2026

Code: QYRE-Auto-32Y361

Report

2026-03-05

Pages:135

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Integrated DNA Technologies

Agilent

Sigma-aldrich

Eurofins Genomics

L.G.C Biosearch Technologies

Eurogentec S.A

Nitto Denko Avecia Inc

GenScript

BBI Life Sciences

GeneDesign

TriLink BioTechnologies

SGS DNA

LC Sciences

Twist Bioscience

Creative Biogene

General Biosystems

Oligonucleotides Market Size

The global Oligonucleotides market was valued at US$ 1656 million in 2025 and is anticipated to reach US$ 3218 million by 2032, at a CAGR of 10.1% from 2026 to 2032.

Oligonucleotides Market

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.

Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.

North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.

In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.

This report delivers a comprehensive overview of the global Oligonucleotides market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oligonucleotides. The Oligonucleotides market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Oligonucleotides market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Oligonucleotides manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Oligonucleotides Market Report

Report Metric	Details
Report Name	Oligonucleotides Market
Accounted market size in 2025	US$ 1656 million
Forecasted market size in 2032	US$ 3218 million
CAGR	10.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	DNA Oligos RNA Oligos
Segment by Application	Pharmaceutical Research Diagnostic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, GenScript, BBI Life Sciences, GeneDesign, TriLink BioTechnologies, SGS DNA, LC Sciences, Twist Bioscience, Creative Biogene, General Biosystems
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Oligonucleotides companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Oligonucleotides Market growing?

Ans: The Oligonucleotides Market witnessing a CAGR of 10.1% during the forecast period 2026-2032.

What is the Oligonucleotides Market size in 2032?

Ans: The Oligonucleotides Market size in 2032 will be US$ 3218 million.

What is the market share of major companies in Oligonucleotides Market?

Ans: Global top five manufacturers hold a share over 45%.

What is the Oligonucleotides Market share by type?

Ans: In terms of product, DNA Oligos is the largest segment, with a share over 65%.

Who are the main players in the Oligonucleotides Market report?

Ans: The main players in the Oligonucleotides Market are Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, GenScript, BBI Life Sciences, GeneDesign, TriLink BioTechnologies, SGS DNA, LC Sciences, Twist Bioscience, Creative Biogene, General Biosystems

What are the Application segmentation covered in the Oligonucleotides Market report?

Ans: The Applications covered in the Oligonucleotides Market report are Pharmaceutical, Research, Diagnostic

What are the Type segmentation covered in the Oligonucleotides Market report?

Ans: The Types covered in the Oligonucleotides Market report are DNA Oligos, RNA Oligos

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oligonucleotides Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 DNA Oligos

1.2.3 RNA Oligos

1.3 Market by Application

1.3.1 Global Oligonucleotides Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Pharmaceutical

1.3.3 Research

1.3.4 Diagnostic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oligonucleotides Market Perspective (2021–2032)

2.2 Global Oligonucleotides Growth Trends by Region

2.2.1 Global Oligonucleotides Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Oligonucleotides Historic Market Size by Region (2021–2026)

2.2.3 Oligonucleotides Forecasted Market Size by Region (2027–2032)

2.3 Oligonucleotides Market Dynamics

2.3.1 Oligonucleotides Industry Trends

2.3.2 Oligonucleotides Market Drivers

2.3.3 Oligonucleotides Market Challenges

2.3.4 Oligonucleotides Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oligonucleotides Players by Revenue

3.1.1 Global Top Oligonucleotides Players by Revenue (2021–2026)

3.1.2 Global Oligonucleotides Revenue Market Share by Players (2021–2026)

3.2 Global Top Oligonucleotides Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Oligonucleotides Revenue

3.4 Global Oligonucleotides Market Concentration Ratio

3.4.1 Global Oligonucleotides Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotides Revenue in 2025

3.5 Global Key Players of Oligonucleotides Head Offices and Areas Served

3.6 Global Key Players of Oligonucleotides, Products and Applications

3.7 Global Key Players of Oligonucleotides, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Oligonucleotides Breakdown Data by Type

4.1 Global Oligonucleotides Historic Market Size by Type (2021–2026)

4.2 Global Oligonucleotides Forecasted Market Size by Type (2027–2032)

5 Oligonucleotides Breakdown Data by Application

5.1 Global Oligonucleotides Historic Market Size by Application (2021–2026)

5.2 Global Oligonucleotides Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Oligonucleotides Market Size (2021–2032)

6.2 North America Oligonucleotides Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Oligonucleotides Market Size by Country (2021–2026)

6.4 North America Oligonucleotides Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oligonucleotides Market Size (2021–2032)

7.2 Europe Oligonucleotides Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Oligonucleotides Market Size by Country (2021–2026)

7.4 Europe Oligonucleotides Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Oligonucleotides Market Size (2021–2032)

8.2 Asia-Pacific Oligonucleotides Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Oligonucleotides Market Size by Region (2021–2026)

8.4 Asia-Pacific Oligonucleotides Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Oligonucleotides Market Size (2021–2032)

9.2 Latin America Oligonucleotides Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Oligonucleotides Market Size by Country (2021–2026)

9.4 Latin America Oligonucleotides Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oligonucleotides Market Size (2021–2032)

10.2 Middle East & Africa Oligonucleotides Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Oligonucleotides Market Size by Country (2021–2026)

10.4 Middle East & Africa Oligonucleotides Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Integrated DNA Technologies

11.1.1 Integrated DNA Technologies Company Details

11.1.2 Integrated DNA Technologies Business Overview

11.1.3 Integrated DNA Technologies Oligonucleotides Introduction

11.1.4 Integrated DNA Technologies Revenue in Oligonucleotides Business (2021–2026)

11.1.5 Integrated DNA Technologies Recent Development

11.2 Agilent

11.2.1 Agilent Company Details

11.2.2 Agilent Business Overview

11.2.3 Agilent Oligonucleotides Introduction

11.2.4 Agilent Revenue in Oligonucleotides Business (2021–2026)

11.2.5 Agilent Recent Development

11.3 Sigma-aldrich

11.3.1 Sigma-aldrich Company Details

11.3.2 Sigma-aldrich Business Overview

11.3.3 Sigma-aldrich Oligonucleotides Introduction

11.3.4 Sigma-aldrich Revenue in Oligonucleotides Business (2021–2026)

11.3.5 Sigma-aldrich Recent Development

11.4 Eurofins Genomics

11.4.1 Eurofins Genomics Company Details

11.4.2 Eurofins Genomics Business Overview

11.4.3 Eurofins Genomics Oligonucleotides Introduction

11.4.4 Eurofins Genomics Revenue in Oligonucleotides Business (2021–2026)

11.4.5 Eurofins Genomics Recent Development

11.5 L.G.C Biosearch Technologies

11.5.1 L.G.C Biosearch Technologies Company Details

11.5.2 L.G.C Biosearch Technologies Business Overview

11.5.3 L.G.C Biosearch Technologies Oligonucleotides Introduction

11.5.4 L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2021–2026)

11.5.5 L.G.C Biosearch Technologies Recent Development

11.6 Eurogentec S.A

11.6.1 Eurogentec S.A Company Details

11.6.2 Eurogentec S.A Business Overview

11.6.3 Eurogentec S.A Oligonucleotides Introduction

11.6.4 Eurogentec S.A Revenue in Oligonucleotides Business (2021–2026)

11.6.5 Eurogentec S.A Recent Development

11.7 Nitto Denko Avecia Inc

11.7.1 Nitto Denko Avecia Inc Company Details

11.7.2 Nitto Denko Avecia Inc Business Overview

11.7.3 Nitto Denko Avecia Inc Oligonucleotides Introduction

11.7.4 Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2021–2026)

11.7.5 Nitto Denko Avecia Inc Recent Development

11.8 GenScript

11.8.1 GenScript Company Details

11.8.2 GenScript Business Overview

11.8.3 GenScript Oligonucleotides Introduction

11.8.4 GenScript Revenue in Oligonucleotides Business (2021–2026)

11.8.5 GenScript Recent Development

11.9 BBI Life Sciences

11.9.1 BBI Life Sciences Company Details

11.9.2 BBI Life Sciences Business Overview

11.9.3 BBI Life Sciences Oligonucleotides Introduction

11.9.4 BBI Life Sciences Revenue in Oligonucleotides Business (2021–2026)

11.9.5 BBI Life Sciences Recent Development

11.10 GeneDesign

11.10.1 GeneDesign Company Details

11.10.2 GeneDesign Business Overview

11.10.3 GeneDesign Oligonucleotides Introduction

11.10.4 GeneDesign Revenue in Oligonucleotides Business (2021–2026)

11.10.5 GeneDesign Recent Development

11.11 TriLink BioTechnologies

11.11.1 TriLink BioTechnologies Company Details

11.11.2 TriLink BioTechnologies Business Overview

11.11.3 TriLink BioTechnologies Oligonucleotides Introduction

11.11.4 TriLink BioTechnologies Revenue in Oligonucleotides Business (2021–2026)

11.11.5 TriLink BioTechnologies Recent Development

11.12 SGS DNA

11.12.1 SGS DNA Company Details

11.12.2 SGS DNA Business Overview

11.12.3 SGS DNA Oligonucleotides Introduction

11.12.4 SGS DNA Revenue in Oligonucleotides Business (2021–2026)

11.12.5 SGS DNA Recent Development

11.13 LC Sciences

11.13.1 LC Sciences Company Details

11.13.2 LC Sciences Business Overview

11.13.3 LC Sciences Oligonucleotides Introduction

11.13.4 LC Sciences Revenue in Oligonucleotides Business (2021–2026)

11.13.5 LC Sciences Recent Development

11.14 Twist Bioscience

11.14.1 Twist Bioscience Company Details

11.14.2 Twist Bioscience Business Overview

11.14.3 Twist Bioscience Oligonucleotides Introduction

11.14.4 Twist Bioscience Revenue in Oligonucleotides Business (2021–2026)

11.14.5 Twist Bioscience Recent Development

11.15 Creative Biogene

11.15.1 Creative Biogene Company Details

11.15.2 Creative Biogene Business Overview

11.15.3 Creative Biogene Oligonucleotides Introduction

11.15.4 Creative Biogene Revenue in Oligonucleotides Business (2021–2026)

11.15.5 Creative Biogene Recent Development

11.16 General Biosystems

11.16.1 General Biosystems Company Details

11.16.2 General Biosystems Business Overview

11.16.3 General Biosystems Oligonucleotides Introduction

11.16.4 General Biosystems Revenue in Oligonucleotides Business (2021–2026)

11.16.5 General Biosystems Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Integrated DNA Technologies

Agilent

Sigma-aldrich

Eurofins Genomics

L.G.C Biosearch Technologies

Eurogentec S.A

Nitto Denko Avecia Inc

GenScript

BBI Life Sciences

GeneDesign

TriLink BioTechnologies

SGS DNA

LC Sciences

Twist Bioscience

Creative Biogene

General Biosystems

List of Tables

Table 1. Global Oligonucleotides Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of DNA Oligos

Table 3. Key Players of RNA Oligos

Table 4. Global Oligonucleotides Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Oligonucleotides Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Oligonucleotides Market Size by Region (US$ Million), 2021–2026

Table 7. Global Oligonucleotides Market Share by Region (2021–2026)

Table 8. Global Oligonucleotides Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Oligonucleotides Market Share by Region (2027–2032)

Table 10. Oligonucleotides Market Trends

Table 11. Oligonucleotides Market Drivers

Table 12. Oligonucleotides Market Challenges

Table 13. Oligonucleotides Market Restraints

Table 14. Global Oligonucleotides Revenue by Players (US$ Million), 2021–2026

Table 15. Global Oligonucleotides Market Share by Players (2021–2026)

Table 16. Global Top Oligonucleotides Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oligonucleotides Revenue, 2025

Table 17. Ranking of Global Top Oligonucleotides Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Oligonucleotides Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Oligonucleotides, Headquarters and Area Served

Table 20. Global Key Players of Oligonucleotides, Products and Applications

Table 21. Global Key Players of Oligonucleotides, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Oligonucleotides Market Size by Type (US$ Million), 2021–2026

Table 24. Global Oligonucleotides Revenue Market Share by Type (2021–2026)

Table 25. Global Oligonucleotides Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Oligonucleotides Revenue Market Share by Type (2027–2032)

Table 27. Global Oligonucleotides Market Size by Application (US$ Million), 2021–2026

Table 28. Global Oligonucleotides Revenue Market Share by Application (2021–2026)

Table 29. Global Oligonucleotides Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Oligonucleotides Revenue Market Share by Application (2027–2032)

Table 31. North America Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Oligonucleotides Market Size by Country (US$ Million), 2021–2026

Table 33. North America Oligonucleotides Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Oligonucleotides Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Oligonucleotides Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Oligonucleotides Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Oligonucleotides Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Oligonucleotides Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Oligonucleotides Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Oligonucleotides Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Oligonucleotides Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Oligonucleotides Market Size by Country (US$ Million), 2027–2032

Table 46. Integrated DNA Technologies Company Details

Table 47. Integrated DNA Technologies Business Overview

Table 48. Integrated DNA Technologies Oligonucleotides Product

Table 49. Integrated DNA Technologies Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 50. Integrated DNA Technologies Recent Development

Table 51. Agilent Company Details

Table 52. Agilent Business Overview

Table 53. Agilent Oligonucleotides Product

Table 54. Agilent Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 55. Agilent Recent Development

Table 56. Sigma-aldrich Company Details

Table 57. Sigma-aldrich Business Overview

Table 58. Sigma-aldrich Oligonucleotides Product

Table 59. Sigma-aldrich Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 60. Sigma-aldrich Recent Development

Table 61. Eurofins Genomics Company Details

Table 62. Eurofins Genomics Business Overview

Table 63. Eurofins Genomics Oligonucleotides Product

Table 64. Eurofins Genomics Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 65. Eurofins Genomics Recent Development

Table 66. L.G.C Biosearch Technologies Company Details

Table 67. L.G.C Biosearch Technologies Business Overview

Table 68. L.G.C Biosearch Technologies Oligonucleotides Product

Table 69. L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 70. L.G.C Biosearch Technologies Recent Development

Table 71. Eurogentec S.A Company Details

Table 72. Eurogentec S.A Business Overview

Table 73. Eurogentec S.A Oligonucleotides Product

Table 74. Eurogentec S.A Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 75. Eurogentec S.A Recent Development

Table 76. Nitto Denko Avecia Inc Company Details

Table 77. Nitto Denko Avecia Inc Business Overview

Table 78. Nitto Denko Avecia Inc Oligonucleotides Product

Table 79. Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 80. Nitto Denko Avecia Inc Recent Development

Table 81. GenScript Company Details

Table 82. GenScript Business Overview

Table 83. GenScript Oligonucleotides Product

Table 84. GenScript Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 85. GenScript Recent Development

Table 86. BBI Life Sciences Company Details

Table 87. BBI Life Sciences Business Overview

Table 88. BBI Life Sciences Oligonucleotides Product

Table 89. BBI Life Sciences Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 90. BBI Life Sciences Recent Development

Table 91. GeneDesign Company Details

Table 92. GeneDesign Business Overview

Table 93. GeneDesign Oligonucleotides Product

Table 94. GeneDesign Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 95. GeneDesign Recent Development

Table 96. TriLink BioTechnologies Company Details

Table 97. TriLink BioTechnologies Business Overview

Table 98. TriLink BioTechnologies Oligonucleotides Product

Table 99. TriLink BioTechnologies Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 100. TriLink BioTechnologies Recent Development

Table 101. SGS DNA Company Details

Table 102. SGS DNA Business Overview

Table 103. SGS DNA Oligonucleotides Product

Table 104. SGS DNA Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 105. SGS DNA Recent Development

Table 106. LC Sciences Company Details

Table 107. LC Sciences Business Overview

Table 108. LC Sciences Oligonucleotides Product

Table 109. LC Sciences Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 110. LC Sciences Recent Development

Table 111. Twist Bioscience Company Details

Table 112. Twist Bioscience Business Overview

Table 113. Twist Bioscience Oligonucleotides Product

Table 114. Twist Bioscience Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 115. Twist Bioscience Recent Development

Table 116. Creative Biogene Company Details

Table 117. Creative Biogene Business Overview

Table 118. Creative Biogene Oligonucleotides Product

Table 119. Creative Biogene Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 120. Creative Biogene Recent Development

Table 121. General Biosystems Company Details

Table 122. General Biosystems Business Overview

Table 123. General Biosystems Oligonucleotides Product

Table 124. General Biosystems Revenue in Oligonucleotides Business (US$ Million), 2021–2026

Table 125. General Biosystems Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

Table 129. Authors List of This Report

List of Figures

Figure 1. Oligonucleotides Picture

Figure 2. Global Oligonucleotides Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Oligonucleotides Market Share by Type: 2025 vs 2032

Figure 4. DNA Oligos Features

Figure 5. RNA Oligos Features

Figure 6. Global Oligonucleotides Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Oligonucleotides Market Share by Application: 2025 vs 2032

Figure 8. Pharmaceutical Case Studies

Figure 9. Research Case Studies

Figure 10. Diagnostic Case Studies

Figure 11. Oligonucleotides Report Years Considered

Figure 12. Global Oligonucleotides Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Oligonucleotides Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Oligonucleotides Market Share by Region: 2025 vs 2032

Figure 15. Global Oligonucleotides Market Share by Players in 2025

Figure 16. Global Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Oligonucleotides Revenue in 2025

Figure 18. North America Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Oligonucleotides Market Share by Country (2021–2032)

Figure 20. United States Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Oligonucleotides Market Share by Country (2021–2032)

Figure 24. Germany Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Oligonucleotides Market Share by Region (2021–2032)

Figure 32. China Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Oligonucleotides Market Share by Country (2021–2032)

Figure 40. Mexico Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Oligonucleotides Market Share by Country (2021–2032)

Figure 44. Israel Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Oligonucleotides Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 48. Agilent Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 49. Sigma-aldrich Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 50. Eurofins Genomics Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 51. L.G.C Biosearch Technologies Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 52. Eurogentec S.A Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 53. Nitto Denko Avecia Inc Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 54. GenScript Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 55. BBI Life Sciences Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 56. GeneDesign Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 57. TriLink BioTechnologies Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 58. SGS DNA Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 59. LC Sciences Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 60. Twist Bioscience Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 61. Creative Biogene Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 62. General Biosystems Revenue Growth Rate in Oligonucleotides Business (2021–2026)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oligonucleotide Market Research Report 2025

Global Oligo Synthesis Market Research Report 2025

Global Oligonucleotide Solid Phase Synthesizer Market Research Report 2024

Oligonucleotide Synthesis Linkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global DNA Oligonucleotide Synthesis Market Insights Forecast to 2030

Global Oligonucleotide Synthesizer Market Research Report 2024

Global Oligonucleotide Synthesis Services Market Insights Forecast to 2030

Global Oligonucleotide Oligo Drugs Market Research Report 2024

Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligo Synthesizer Market Insights Forecast to 2030

Global Oligonucleotide Drug Carriers Market Research Report 2024

Global Oligonucleotide Therapeutics Market Research Report 2024

Global DNA and RNA Oligonucleotide Synthesizers Market Research Report 2024

Global Phosphoramidites for Oligonucleotides Market Research Report 2024

Global Automated Oligonucleotide Synthesizer Market Research Report 2024

Global Solid phase Oligonucleotide Synthesis Market Research Report 2025

DNA And RNA Synthesis Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oligonucleotide Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Drugs ONs Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions